Kaletra is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in people 14 days and older in combination with other antiretroviral drugs. Kaletra is a combination drug composed of Lopinavir and Ritonavir, which are also known respectively by the abbreviations LPV/r or LPV and RTV.
Lopinavir and Ritonavir are antiviral medication of the protease inhibitor (PI) class. Both drugs are believed to work by preventing HIV from replicating in cells.
How do I take it?
Prescribing information states that Kaletra is taken once or twice a day.
Kaletra comes in tablet and oral solution forms.
The FDA-approved label for Kaletra lists common side effects including nausea, diarrhea, vomiting, raised levels of cholesterol and triglycerides, and changes in the shape or location of body fat.
Rare but serious side effects listed for Kaletra include severe hypersensitivity reactions, liver damage, and new or worsening cases of diabetes or immune reconstitution syndrome.
For more details about this treatment, visit:
Kaletra highlights of prescribing information – AbbVie
Overview of HIV Treatments – AIDS.gov